On ECHEMI
Home > Drugs > Yunnan Yuyao Biopharmaceutical Co., Ltd.
Yunnan Yuyao Biopharmaceutical Co., Ltd.
  • Founded in:

    2002-03-27
  • Country:

    China China
  • Address:

    Yunnan Province Yuxi City High-tech Development Zone
  • Tax NO.:

    91530400734330834G
  • Registered Funds:

    65 million yuan
  • Website:

  • Email:

Related Drugs
Panax notoginseng flower and leaf granules
Panax notoginseng leaf stem and Panax notoginseng flower.
Name Description Content CAS NO. Registered Holders
Panax notoginseng leaf stem

0
FLOS PANAX NOTEGINSENG

0
Panax notoginseng flower and leaf granules
Panax notoginseng leaf stem and Panax notoginseng flower.
Name Description Content CAS NO. Registered Holders
Panax notoginseng leaf stem

0
FLOS PANAX NOTEGINSENG

0
Breviscapine injection
Breviscapine.
Name Description Content CAS NO. Registered Holders
BREVISCAPIN

1. Dilate microvessels, improve microcirculation, enhance myocardial function and blood supply to the heart and brain. 2. Reduce blood viscosity, resist platelet aggregation, prevent thrombosis and dissolve thrombus. 3. Lower blood sugar and blood lipids.

More

1. Dilate microvessels, improve microcirculation, enhance myocardial function and blood supply to the heart and brain. 2. Reduce blood viscosity, resist platelet aggregation, prevent thrombosis and dissolve thrombus. 3. Lower blood sugar and blood lipids.

116122-36-2 0
Cefuroxime dry suspension
The main ingredient is sodium bicarbonate.
Name Description Content CAS NO. Registered Holders
Sodium bicarbonate

1. Treat metabolic acidosis. This product increases the concentration of carbonate in plasma and neutralizes hydrogen ions, thereby correcting acidosis. 2. Alkalinize urine. As the pH value increases after the concentration of bicarbonate in urine increases, uric acid, sulfonamide drugs and hemoglobin are not easy to form crystals or aggregate in urine. 3. Antacid. Oral administration can quickly neutralize or buffer gastric acid without directly affecting gastric acid secretion. Therefore, the pH in the stomach increases rapidly to relieve the symptoms caused by high gastric acid.

More

1. Treat metabolic acidosis. This product increases the concentration of carbonate in plasma and neutralizes hydrogen ions, thereby correcting acidosis. 2. Alkalinize urine. As the pH value increases after the concentration of bicarbonate in urine increases, uric acid, sulfonamide drugs and hemoglobin are not easy to form crystals or aggregate in urine. 3. Antacid. Oral administration can quickly neutralize or buffer gastric acid without directly affecting gastric acid secretion. Therefore, the pH in the stomach increases rapidly to relieve the symptoms caused by high gastric acid.

144-55-8 44
Cefuroxime dry suspension
The main ingredient of this product is cefradine, and its chemical name is: (6R,7R)-7[(R)-2-amino-2-(1,4-cyclohexenyl)acetylamino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid.
Name Description Content CAS NO. Registered Holders
Cefradine

This product is a first-generation cephalosporin, which has good antibacterial effect on some strains of Gram-positive cocci such as non-penicillinase-producing and penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococci, group A hemolytic streptococci, Streptococcus pneumoniae and viridans streptococci. Anaerobic Gram-positive bacteria are mostly sensitive to this product, and Bacteroides fragilis is resistant to this product. Methicillin-resistant Staphylococci and Enterococci are resistant to this product. The effect of this product on Gram-positive and Gram-negative bacteria is similar to that of cephalexin. This product has a certain effect on gonococci and is also active against enzyme-producing gonococci; its activity against Haemophilus influenzae is poor.

More

This product is a first-generation cephalosporin, which has good antibacterial effect on some strains of Gram-positive cocci such as non-penicillinase-producing and penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococci, group A hemolytic streptococci, Streptococcus pneumoniae and viridans streptococci. Anaerobic Gram-positive bacteria are mostly sensitive to this product, and Bacteroides fragilis is resistant to this product. Methicillin-resistant Staphylococci and Enterococci are resistant to this product. The effect of this product on Gram-positive and Gram-negative bacteria is similar to that of cephalexin. This product has a certain effect on gonococci and is also active against enzyme-producing gonococci; its activity against Haemophilus influenzae is poor.

38821-53-3 27
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.